Open label extension studies: research or marketing?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16150772.
- Also identified by PMC identifier 1200598.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Open label extension studies allow continued prescribing of unlicensed drugs after a randomised trial, but it is unclear whether patients or drug companies are benefiting the most
Medical subject headings
- Drug Evaluation